MNDL Bio is building the predictive engine for scalable protein production.

AI has accelerated protein discovery -  but manufacturing remains one of biotech’s biggest bottlenecks. Companies still spend years in costly trial-and-error cycles trying to achieve stable, high-yield protein expression at industrial scale.

We replace that uncertainty with software.

Our AI-powered engineering engine combines mechanistic biophysical modeling with generative algorithms to design full genetic construct architecture - not just codon optimization. We engineer manufacturability at the DNA level, improving the probability of high, stable expression before expensive scale-up and CMC processes begin.

Built on 15+ years of research led by our CSO, Prof. Tamir Tuller, our proprietary models form a defensible scientific core, strengthened by a growing real-world data flywheel.

We work with biotech, biopharma, enzyme, and synthetic biology teams to:

• Increase protein yield
• Reduce development timelines
• Lower scale-up risk
• Improve production robustness

MNDL Bio is a scalable software platform designed for enterprise deployment across global protein development pipelines.

Predictable biology starts with engineered DNA.

MNDL Bio

The TEL AVIV office focuses on innovative research and development initiatives in technology and startups.

MNDL Bio

Org chart

Teams

Offices

MNDL Bio

Org chart

Teams

Offices

Related companies